Effect of Weight Loss on Activity in Psoriatic Arthritis: A Systematic Review

Bhole, 2012, Differences in body mass index among individuals with PsA, psoriasis, RA and the general population, Rheumatology (Oxford), 51, 552, 10.1093/rheumatology/ker349 Jamnitski, 2013, Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review, Ann Rheum Dis, 72, 211, 10.1136/annrheumdis-2011-201194 Kumar, 2013, Obesity, waist circumference, weight change and the risk of psoriasis in US women, J Eur Acad Dermatol Venereol, 27, 1293, 10.1111/jdv.12001 Love, 2012, Obesity and the risk of psoriatic arthritis: a population-based study, Ann Rheum Dis, 71, 1273, 10.1136/annrheumdis-2012-201299 Li, 2012, Obesity and risk of incident psoriatic arthritis in US women, Ann Rheum Dis, 71, 1267, 10.1136/annrheumdis-2011-201273 Armstrong, 2012, The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies, Nutr Diabetes, 2, e54, 10.1038/nutd.2012.26 Ahima, 2000, Adipose tissue as an endocrine organ, Trends Endocrinol Metab, 11, 327, 10.1016/S1043-2760(00)00301-5 Yudkin, 1999, C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue, Arterioscler Thromb Vasc Biol, 19, 972, 10.1161/01.ATV.19.4.972 Zulet, 2007, [Inflammatory biomarkers: the link between obesity and associated pathologies], Nutr Hosp, 22, 511 Rondinone, 2006, Adipocyte-derived hormones, cytokines, and mediators, Endocrine, 29, 81, 10.1385/ENDO:29:1:81 Carrascosa, 2014, Body mass index in patients with moderate-to-severe psoriasis in Spain and its impact as an independent risk factor for therapy withdrawal: results of the Biobadaderm Registry, J Eur Acad Dermatol Venereol, 28, 907, 10.1111/jdv.12208 Zhang, 2011, The effect of overweight and obesity on psoriasis patients in Chinese Han population: a hospital-based study, J Eur Acad Dermatol Venereol, 25, 87, 10.1111/j.1468-3083.2010.03706.x Di Minno, 2014, Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor alpha blockers, Ann Rheum Dis, 73, 1157, 10.1136/annrheumdis-2012-202812 Eder, 2015, Obesity is associated with a lower probability of achieving sustained minimal disease activity state among patients with psoriatic arthritis, Ann Rheum Dis, 74, 813, 10.1136/annrheumdis-2013-204448 Hermsdorff, 2009, Discriminated benefits of a Mediterranean dietary pattern within a hypocaloric diet program on plasma RBP4 concentrations and other inflammatory markers in obese subjects, Endocrine, 36, 445, 10.1007/s12020-009-9248-1 Nicklas, 2004, Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial, Am J Clin Nutr, 79, 544, 10.1093/ajcn/79.4.544 Jensen, 2013, Effect of weight loss on the severity of psoriasis: a randomized clinical study, JAMA Dermatol, 149, 795, 10.1001/jamadermatol.2013.722 Lundh, 2008, Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies, BMC Med Res Methodol, 8, 22, 10.1186/1471-2288-8-22 Abou-Raya, 2014, Effect of exercise and dietary weight loss on symptoms and systemic inflammation in obese adults with psoriatic arthritis: randomized controlled trial, Ann Rheum Dis, 74 Coates, 2010, Validation of minimal disease activity criteria for psoriatic arthritis using interventional trial data, Arthritis Care Res (Hoboken), 62, 965, 10.1002/acr.20155 Gladman, 1998, Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death, Arthritis Rheum, 41, 1103, 10.1002/1529-0131(199806)41:6<1103::AID-ART18>3.0.CO;2-N Gladman, 2009, Cardiovascular morbidity in psoriatic arthritis, Ann Rheum Dis, 68, 1131, 10.1136/ard.2008.094839 Kimhi, 2007, Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis, Semin Arthritis Rheum, 36, 203, 10.1016/j.semarthrit.2006.09.001 Mok, 2011, Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis, Arthritis Care Res (Hoboken), 63, 195, 10.1002/acr.20363 Raychaudhuri, 2010, Increased prevalence of the metabolic syndrome in patients with psoriatic arthritis, Metab Syndr Relat Disord, 8, 331, 10.1089/met.2009.0124 Tam, 2008, Cardiovascular risk profile of patients with psoriatic arthritis compared to controls—the role of inflammation, Rheumatology (Oxford), 47, 718, 10.1093/rheumatology/ken090 Zisman, 2012, Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel, Rheumatol Int, 32, 595, 10.1007/s00296-010-1673-1 Galindez, 2016, Is obesity in psoriatic arthritis associated with a poorer therapeutic response and more adverse effects of treatment with an anchor drug?, Reumatol Clin, 12, 307 Escarcega, 2006, Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease, Autoimmun Rev, 6, 48, 10.1016/j.autrev.2006.07.001 Yudkin, 2000, Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?, Atherosclerosis, 148, 209, 10.1016/S0021-9150(99)00463-3 Broadbent, 2011, Illness and treatment perceptions are associated with adherence to medications, diet, and exercise in diabetic patients, Diabetes Care, 34, 338, 10.2337/dc10-1779